Systems biology approach to optimize tissue growth in vitro
Systems biology approach to optimize tissue growth in vitro
批准号:
8149855
负责人:
ROBERT T TRANQUILLO
金额:
$17.45万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-30 至 2013-08-31
关键词:
Cell ProliferationCellsChemical StimulationChemicalsCollagenConnective TissueDataDepositionDimensionsElasticityElastinExtracellular MatrixFibrinFilmFutureGenerationsGrowthHarvestHistologyIn SituIn VitroKnowledgeLeadLeast-Squares AnalysisMass Spectrum AnalysisMeasuresMechanical StimulationMechanicsMembraneMembrane ProteinsMethodsModelingPathway interactionsPatternPhosphoproteinsPrincipal Component AnalysisProductionPropertyProteinsResearchSamplingSeriesSignal PathwaySignal TransductionSiliconesStatistical ModelsStimulusStretchingSystemSystems BiologyTestingTimeTissue EngineeringTissuesTubeTubular formationUpdateVisionWeightbaseextracellularimprovedin vivointerestmathematical modelpublic health relevanceresearch studyresponsevascular tissue engineering
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Despite a large and increasing research effort aimed at growing functional connective tissues in vitro, with few exceptions they lack the required functionality because the tissue growth is limited and the resulting material/mechanical properties are inadequate for in vivo applications. While chemical and mechanical signals, alone or in combination, can indeed lead to improved tissue growth as measured by material/mechanical properties, the current paradigm of applying these signals at fixed levels for the entire period of tissue growth is almost certainly suboptimal. The vision for the proposed project is to develop a rational basis for optimizing in vitro tissue growth via combined chemical and mechanical stimulation that does not require knowledge of the signal generation and transduction mechanisms, which are so daunting in complexity that a "first principles" model is unrealizable for the foreseeable future. It is inspired by a systems biology approach recently advanced by Janes and Lauffenburger (Janes, Kelly et al. 2004) based on principal component analysis and discriminate partial least squares regression that we will extend to determine a statistical relation between long-term "downstream" cell responses of interest (collagen and elastin production and associated tissue mechanical properties) and a subset of short-term "upstream" intracellular signals (i.e. phosphorylated proteins) that are generated due to extracellular stimuli. Having determined this "signal-response reduction" from a series of long-term step-response experiments on cells subject to various concentrations of chemical (e.g. TGF-b1) and mechanical (stretching) stimulation, an "experimental steepest descent" strategy will then be implemented to drive the cells as they grow a tissue to produce the maximum amount of collagen and elastin, which should maximize the tissue strength and modulus while imparting elasticity. This will be accomplished by periodically performing short-term step-response ("interrogation") experiments in situ and using the predetermined reduction to predict the optimal combination of TGF-b1 concentration and stretching conditions for the subsequent incubation period, after which the tissue is again interrogated and the optimal conditions are again updated, and so on. If successful, this paradigm would dramatically change the field of tissue engineering and likely elucidate signaling pathways that lead to deposition of extracellular matrix components.
PUBLIC HEALTH RELEVANCE: Few attempts to grow functional tissue replacements have succeeded. In order to grow stiffer and stronger tissues, a rationale is needed to choose the incubation conditions. In this project, high- throughput cell signaling data will be obtained periodically during the incubation to adjust the incubation conditions so that tissue growth is improved.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biologically-engineered Transcatheter Vein Valve: Design Optimization and Preclinical Testing
-
批准号:10594865
-
项目类别:
-
资助金额:$38.57万
-
财政年份:2023
-
负责人:ROBERT T TRANQUILLO
-
依托单位:
Biopolymer-guided human stem cell assembly for engineered myocardium
-
批准号:8328585
-
项目类别:
-
资助金额:$74.44万
-
财政年份:2011
-
负责人:ROBERT T TRANQUILLO
-
依托单位:
Completely biological tissue-engineered pulmonic valve grown in vitro from human
-
批准号:8083856
-
项目类别:
-
资助金额:$56.87万
-
财政年份:2011
-
负责人:ROBERT T TRANQUILLO
-
依托单位:
Completely biological tissue-engineered pulmonic valve grown in vitro from human cells for pediatric patients
-
批准号:10188591
-
项目类别:
-
资助金额:$72.11万
-
财政年份:2011
-
负责人:ROBERT T TRANQUILLO
-
依托单位:
Tissue-engineered pulmonic valve grown from human cells for pediatric patients
-
批准号:8527302
-
项目类别:
-
资助金额:$3.77万
-
财政年份:2011
-
负责人:ROBERT T TRANQUILLO
-
依托单位:
Perfusable and beating engineered myocardium from human progenitor cells based on
-
批准号:8138261
-
项目类别:
-
资助金额:$71.56万
-
财政年份:2011
-
负责人:ROBERT T TRANQUILLO
-
依托单位:
Completely biological tissue-engineered pulmonic valve grown in vitro from human cells for pediatric patients
-
批准号:9520733
-
项目类别:
-
资助金额:$70.64万
-
财政年份:2011
-
负责人:ROBERT T TRANQUILLO
-
依托单位:
Tissue-engineered pulmonic valve grown from human cells for pediatric patients
-
批准号:8242099
-
项目类别:
-
资助金额:$65.67万
-
财政年份:2011
-
负责人:ROBERT T TRANQUILLO
-
依托单位:
Biopolymer-guided human stem cell assembly for engineered myocardium
-
批准号:8529260
-
项目类别:
-
资助金额:$70.77万
-
财政年份:2011
-
负责人:ROBERT T TRANQUILLO
-
依托单位:
Tissue-engineered pulmonic valve grown from human cells for pediatric patients
-
批准号:8649073
-
项目类别:
-
资助金额:$69.42万
-
财政年份:2011
-
负责人:ROBERT T TRANQUILLO
-
依托单位:
Tissue-engineered pulmonic valve grown from human cells for pediatric patients
-
批准号:8828279
-
项目类别:
-
资助金额:$64.69万
-
财政年份:2011
-
负责人:ROBERT T TRANQUILLO
-
依托单位:
Biopolymer-guided human stem cell assembly for engineered myocardium
-
批准号:8676917
-
项目类别:
-
资助金额:$72.74万
-
财政年份:2011
-
负责人:ROBERT T TRANQUILLO
-
依托单位:
Tissue-engineered pulmonic valve grown from human cells for pediatric patients
-
批准号:8449249
-
项目类别:
-
资助金额:$66.23万
-
财政年份:2011
-
负责人:ROBERT T TRANQUILLO
-
依托单位:
Systems biology approach to optimize tissue growth in vitro
-
批准号:8045211
-
项目类别:
-
资助金额:$20.93万
-
财政年份:2010
-
负责人:ROBERT T TRANQUILLO
-
依托单位:
Engineered Artery Growth in Vitro Based on Cell-Remodeled Fibrin
-
批准号:7645736
-
项目类别:
-
资助金额:$82.45万
-
财政年份:2006
-
负责人:ROBERT T TRANQUILLO
-
依托单位:
Engineered Artery Growth in Vitro Based on Cell-Remodeled Fibrin
-
批准号:7878734
-
项目类别:
-
资助金额:$83.06万
-
财政年份:2006
-
负责人:ROBERT T TRANQUILLO
-
依托单位:
Engineered Artery Growth in Vitro Based on Cell-Remodeled Fibrin
-
批准号:7456366
-
项目类别:
-
资助金额:$96.37万
-
财政年份:2006
-
负责人:ROBERT T TRANQUILLO
-
依托单位:
Engineered Artery Growth in Vitro, Cell-Remodeled Fibrin
-
批准号:7069323
-
项目类别:
-
资助金额:$55.49万
-
财政年份:2006
-
负责人:ROBERT T TRANQUILLO
-
依托单位:
Engineered Artery Growth in Vitro Based on Cell-Remodeled Fibrin
-
批准号:7243419
-
项目类别:
-
资助金额:$68.98万
-
财政年份:2006
-
负责人:ROBERT T TRANQUILLO
-
依托单位:
Tissue-engineering Valve from Cell-Remodeled Biopolymer
-
批准号:6748445
-
项目类别:
-
资助金额:$74.38万
-
财政年份:2003
-
负责人:ROBERT T TRANQUILLO
-
依托单位:
国内基金
海外基金
登录
查看更多内容
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:肖将尉
-
依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
-
批准号:82072862
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:徐云升
-
依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
-
批准号:82070825
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2020
-
负责人:徐西振
-
依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
-
批准号:81903002
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:王斐斐
-
依托单位:
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
-
批准号:81402419
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:杨翠霞
-
依托单位:
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
-
批准号:81271563
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:陈正光
-
依托单位:
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
-
批准号:31272541
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2012
-
负责人:王春凤
-
依托单位:
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
-
批准号:31271248
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:李伟
-
依托单位:
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
-
批准号:81160050
-
项目类别:地区科学基金项目
-
资助金额:49.0万元
-
批准年份:2011
-
负责人:邵立健
-
依托单位: